Introduction: The COVID-19 pandemic has changed the immunological status of the
population, indicating increased activation. The aim of the study was to compare the degree …

Introduction Patients with cardiovascular disease (CVD) and acute SARS-CoV-2 infection
might show an altered immune response during COVID-19. Material and methods Twenty …

We have read with great interest the “Letter to the Editor” by Patoulias et al.[1] with
comments on our study [2]. The anticipated more severe course of COVID-19 is partially …

Results: A total of 22 patients were infected in the immediate postoperative period in spite of
appropriate screening and had a high mortality of 36.36%(vs. non-COVID 6.27%, P< 0.001) …

Background: During the COVID-19 outbreak, the number of patients who have developed
acute coronary syndromes (ACS) has soared rapidly, cardiovascular disease and mortality …

Objective To longitudinally assess the level of pro-inflammatory cytokines (IL-1β and TNF-α)
in individuals with lingering cardiovascular disturbances two-years after acute severe …

Methods: Our study included 43 patients diagnosed with AMI and 50 patients diagnosed
with COVID-19. We quantified the levels of 41 cytokines in blood serum using xMAP …

Abstract Background/Introduction The COVID-19 pandemic challenged global healthcare
systems by causing a multi-organ syndrome with a high mortality rate. COVID-19 infection is …

We have read with great interest the results of the pilot study conducted by Rola et al.[1],
who demonstrated in a cohort of 24 individuals with long COVID-19 syndrome after …

Aims SARS-CoV-2 infection is associated with adverse outcomes in patients with
cardiovascular disease. Here, we analyzed whether specific biomarkers predict the clinical …